Skip to main content
. 2015 Sep-Oct;20(5):58–65. doi: 10.1590/2177-6709.20.5.058-065.oar

Table 3. - Articles related to osteoprotegerin enclosed in the present review according to the inclusion/exclusion criteria.

Author Study design Aim of the study Sample size Conclusion
Dunn M, et al32Michigan, USA 2007 . Case control Assessment of OPG in regulating mechanically induced bone modeling in a rat model of orthodontic tooth movement. 39 male Sprague-Dawley rats » 9 rats without appliances: (3 rats without injections, 3 rats with vehicle and 3 rats with high-dose OPG) » 30 rats with orthodontic forces: (10 rats with 0.5 mg/Kg OPG-Fc, 10 rats with 5.0 mg/Kg OPG-Fc and 10 rats with vehicle) Local delivery of OPG-Fc inhibits osteoclastogenesis and tooth movement at targeted dental sites.
Keles A, et al31Boston USA 2007 Case control Evaluation of the efficacy of pamidronateversus osteoprotegerin (OPG) in the inhibition of bone resorption and tooth movement. 18 C57Bl/6 male mice into 3 groups of 6 mice: » Control group (vehicle) » 5 mg/kg-1 pamidronate » 10 mg/kg-1 OPG OPG results in a more powerful inhibitor of osteoclast recruitment and activity than pamidronate, with a reduction of osteoclasts number of 95% and tooth movement of 77%.